Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet
Takahiro Hiraide, Yoshihiko Suzuki, Satoko Yamamoto, Soroku Yagihashi, Motoaki Sano · 2025
Read Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet by Takahiro Hiraide, Yoshihiko Suzuki, Satoko Yamamoto, Soroku Yagihashi, Motoaki Sano (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12750934.txt.
Description
Takahiro Hiraide and co-authors report striking loyalty to a diabetes drug among Japanese patients in a study from 2025. Tirzepatide is a dual-action drug with strong trial results. In Western use, six to ten percent of patients quit, mostly over stomach side effects. The Japanese real-world picture looks far brighter.
Two hundred nineteen patients were followed in routine care. Only about one percent stopped the drug. Food questionnaires showed appetites for fatty, high-calorie foods fell. Patients kept eating low-carb traditional foods such as fish and meat. The authors credit that diet pattern for the gentle ride. Culture and cuisine may decide whether a powerful drug stays usable.
Catalog record
| CREATOR | Takahiro Hiraide, Yoshihiko Suzuki, Satoko Yamamoto, Soroku Yagihashi, Motoaki Sano |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |